KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Monday
Nov011999

NCT00003638

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Conditions: Breast Cancer
Sponsors: Oncothyreon Canada Inc.
Phase III

Monday
Nov011999

NCT00003357

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Conditions: Breast Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I

Monday
Nov011999

NCT00002787

Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Conditions: Multiple Myeloma, Plasma Cell Neoplasm
Sponsors: Fred Hutchinson Cancer Research Center, National Cancer institute (NCI)
Phase I

Monday
Nov011999

NCT00003819

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate

Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I

Page 1 ... 12 13 14 15 16